DN2 COST-UTILITY ANALYSIS IN A UK SETTING OF SELF MONITORING OF BLOOD GLUCOSE IN PATIENTS WITH TYPE-2 DIABETES

Value in Health ◽

10.1016/s1098-3015(10)67184-7 ◽

2005 ◽

Vol 8 (6) ◽

pp. A14-A15 ◽

Author(s):

AJ Palmer ◽

S Dinneen ◽

JR Gavin ◽

A Gray ◽

WH Herman ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Self Monitoring

Download Full-text

Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes

Current Medical Research and Opinion ◽

10.1185/030079906x104669 ◽

2006 ◽

Vol 22 (5) ◽

pp. 861-872 ◽

Author(s):

Andrew J. Palmer ◽

Sean Dinneen ◽

James R. Gavin III ◽

Alastair Gray ◽

William H. Herman ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Self Monitoring

Download Full-text

PDB15 SELF MONITORING OF BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES: COST UTILITY ANALYSIS IN AN ITALIAN SETTING

Value in Health ◽

10.1016/s1098-3015(10)63285-8 ◽

2006 ◽

Vol 9 (6) ◽

pp. A228

Author(s):

AJ Palmer ◽

ME Minshall ◽

WJ Valentine ◽

V Foos ◽

SL Tunis

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Self Monitoring

Download Full-text

PDB16 SELF MONITORING OF BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES: COST UTILITY ANALYSIS IN A FRENCH GOVENMENT PAYER SETTING

Value in Health ◽

10.1016/s1098-3015(10)63286-x ◽

2006 ◽

Vol 9 (6) ◽

pp. A228-A229

Author(s):

AJ Palmer ◽

ME Minshall ◽

WJ Valentine ◽

V Foos ◽

SL Tunis

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Self Monitoring

Download Full-text

PDB17 SELF MONITORING OF BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES: COST UTILITY ANALYSIS IN A GERMAN GOVENMENT PAYER SETTING

Value in Health ◽

10.1016/s1098-3015(10)63287-1 ◽

2006 ◽

Vol 9 (6) ◽

pp. A229

Author(s):

AJ Palmer ◽

ME Minshall ◽

WJ Valentine ◽

V Foos ◽

SL Tunis

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Self Monitoring

Download Full-text

DB4 SELF MONITORING OF BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES: COST UTILITY ANALYSIS IN A UNITED STATES THIRD-PARTY PAYER SETTING

Value in Health ◽

10.1016/s1098-3015(10)63158-0 ◽

2006 ◽

Vol 9 (6) ◽

pp. A188

Author(s):

AJ Palmer ◽

ME Minshall ◽

WJ Valentine ◽

V Foos ◽

SL Tunis

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Blood Glucose ◽

Cost Utility ◽

Cost Utility Analysis ◽

Third Party ◽

Utility Analysis ◽

Self Monitoring ◽

Download Full-text

Cost-Utility Analysis of Intensive Blood Glucose Control with Metformin versus Usual Care in Overweight Type 2 Diabetes Mellitus Patients in Beijing, P.R. China

Value in Health ◽

10.1111/j.1524-4733.2008.00363.x ◽

2008 ◽

Vol 11 ◽

pp. S23-S32 ◽

Author(s):

Xuanqian Xie ◽

Hindrik Vondeling

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Blood Glucose ◽

Glucose Control ◽

Blood Glucose Control ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis

Download Full-text

Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: a cost-utility analysis based on the EXSCEL trial

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.109152 ◽

2021 ◽

pp. 109152

Author(s):

Frauke Becker ◽

Helen A. Dakin ◽

Shelby D. Reed ◽

Yanhong Li ◽

José Leal ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Lifetime Cost ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis

Download Full-text

Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China

Diabetes Metabolic Syndrome and Obesity Targets and Therapy ◽

10.2147/dmso.s266901 ◽

2020 ◽

Vol Volume 13 ◽

pp. 2823-2831

Author(s):

Peng Men ◽

Tianbi Liu ◽

Suodi Zhai

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Risk ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

High Cardiovascular Risk ◽

Download Full-text

PDB79 - COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA

Value in Health ◽

10.1016/j.jval.2018.09.784 ◽

2018 ◽

Vol 21 ◽

pp. S131-S132

Author(s):

M. Bogdanovic ◽

M. Fournier ◽

D. Vitezic

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Cost Utility ◽

Cost Utility Analysis ◽

Insulin Degludec ◽

Utility Analysis

Download Full-text

Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add‐on to metformin monotherapy in Type 2 diabetes mellitus

Diabetic Medicine ◽

10.1111/j.1464-5491.2011.03429.x ◽

2012 ◽

Vol 29 (3) ◽

pp. 313-320 ◽

Author(s):

M. J. Davies ◽

B. D. Chubb ◽

I. C. Smith ◽

W. J. Valentine

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Metformin Monotherapy

Download Full-text